DBN1 and Alzheimer disease: For instance, neuronal loss in the hippocampi of AD patients is approximately 5–40% while the loss of postsynaptic proteins such as the developmentally regulated actin-regulating brain protein (drebrin), which is targeted by Aβ oligomers, reaches 70–95% [71].